C12Y205/01018 - CPC Classification Index

#1

20260116933

2026-04-30

INHIBITORS OF NFAT AND NFKB SIGNALING FOR IMPROVING IMMUNE CELL FUNCTION

#2

20250326799

2025-10-23

AGENTS INDUCING VASCULARISATION

#3

20250060359

2025-02-20

FUSION PROTEINS AND METHODS FOR MONITORING FIBRONECTIN MATRIX ASSEMBLY

#4

20240425862

2024-12-26

SIRNA STRUCTURES FOR HIGH ACTIVITY AND REDUCED OFF TARGET

#5

20240392261

2024-11-28

FACTOR FOR DIRECT CONVERSION OF MOTOR NERVE CELLS

#6

20240263203

2024-08-08

RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF TETRAKETIDE DERIVATIVES

#7

20230392147

2023-12-07

MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN

#8

20220356501

2022-11-10

ENGINEERED CELLS FOR INCREASED PRODUCTION OF DIFFICULT-TO-EXPRESS PROTEINS

#9

20220275373

2022-09-01

METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION

#10

20220267779

2022-08-25

SiRNA structures for high activity and reduced off target

#11

20220007605

2022-01-13

Method of generating plants having white foliage

#12

20210395316

2021-12-23

TRANSGENIC PLANT HAVING HERBICIDE RESISTANCE

#13

20210308189

2021-10-07

METHODS, COMPOSITIONS, AND KITS FOR IMPROVING PANCREATIC BETA CELL VIABILITY AND TREATING DISEASES OR CONDITIONS RELATED TO BETA CELL DESTRUCTION

#14

20210123053

2021-04-29

Mammalian cells for producing a secreted protein

#15

20210095265

2021-04-01

In vitro methods of chemical conversion using non-stereospecific glutathione lyases

#16

20210093679

2021-04-01

ENGINEERED GUT MICROBES AND USES THEREOF

#17

20210009648

2021-01-14

PEPTIDES FOR TREATMENT OF DIABETES

#18

20200383288

2020-12-10

METHOD OF GENERATING PLANTS HAVING WHITE FOLIAGE

#19

20200345782

2020-11-05

Stem cell subpopulations with differential GSTT1 expression or genotype

#20

20200276263

2020-09-03

Treatments of oxidative stress conditions

#21

20200165605

2020-05-28

Mammalian cells for producing a secreted protein

#22

20200095297

2020-03-26

Peptides for treatment of diabetes

#23

20190390203

2019-12-26

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

#24

20190367926

2019-12-05

Methods and compositions for treating malignant tumors associated with KRAS mutation

#25

20190338010

2019-11-07

Fusion proteins of collagen-binding domain and parathyroid hormone

#26

20190323015

2019-10-24

SiRNA structures for high activity and reduced off target

#27

20190271697

2019-09-05

Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains

#28

20190263874

2019-08-29

Transgenic plant having herbicide resistance

#29

20190162713

2019-05-30

Analysis method of protein-protein interaction and a screening method of protein-protein interaction inhibitors using a nanopore

#30

20190135890

2019-05-09

Fusion proteins of collagen-binding domain and parathyroid hormone

#31

20190048329

2019-02-14

In vitro methods for processing lignin and other aromatic compounds

#32

20190015456

2019-01-17

Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction

#33

20180319838

2018-11-08

CONJUGATION METHODS FOR MODIFYING OR IMMOBILIZING PROTEINS

#34

20180296635

2018-10-18

Protein particles comprising disulfide crosslinkers and uses related thereto

#35

20180256511

2018-09-13

CLATHRIN THERAPEUTIC FOR NEUROPSYCHIATRIC DISEASES & DISORDERS

#36

20180256510

2018-09-13

CLATHRIN THERAPEUTIC FOR PSYCHIATRIC DISORDERS

#37

20180221436

2018-08-09

Treatments of oxidative stress conditions

#38

20180207106

2018-07-26

PROTEIN COATING COMPOSITION

#39

20180179545

2018-06-28

Reduction of lipase activity in product formulations

#40

20180094033

2018-04-05

Nucleic acids and proteins from streptococcus groups A and B

#41

20180074072

2018-03-15

Hybrid protein for the identification of neddylated substrates

#42

20180055020

2018-03-01

Mice with transgene of iBox peptide inhibitor of group B p21-activated kinases

#43

20180017556

2018-01-18

Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains

#44

20170166898

2017-06-15

siRNA structures for high activity and reduced off target

#45

20170165289

2017-06-15

Methods and compositions for treating malignant tumors associated with kras mutation

#46

20170152559

2017-06-01

METHODS FOR DETERMINING GENE-NUTRIENT INTERACTIONS

#47

20170143766

2017-05-25

STEM CELL SUBPOPULATIONS WITH DIFFERENTIAL GSTT1 EXPRESSION OR GENOTYPE

#48

20170121730

2017-05-04

PLANTS HAVING ALTERED AGRONOMIC CHARACTERISTICS UNDER ABIOTIC CONDITIONS AND RELATED CONSTRUCTS AND METHODS INVOLVING ABIOTIC TOLERANCE GENES

#49

20170101457

2017-04-13

Fusion proteins of collagen-binding domain and parathyroid hormone

#50

20170035843

2017-02-09

COMPOSITION TO REPURPOSE DRUGS

#51

20160355823

2016-12-08

Control of Varroa mite infestation

#52

20160312226

2016-10-27

Reduction of lipase activity in product formulations

#53

20160264947

2016-09-15

Zinc binding fusion protein of glutathione S-transferase and metallothionein

#54

20160264632

2016-09-15

Nucleic acids and proteins from streptococcus groups A and B

#55

20160215029

2016-07-28

Polypeptides comprising an ice-binding activity

#56

20160175405

2016-06-23

Fusion proteins and methods for treating HIV infection and AIDS related symptoms

#57

20160151423

2016-06-02

Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction

#58

20160145605

2016-05-26

PEPTIDE-PRESENTING PROTEIN AND PEPTIDE LIBRARY USING SAME

#59

20160137965

2016-05-19

Cell culture vessel coated with laminin fragment in dry state

#60

20160038571

2016-02-11

Method and compositions for treatment of calcineurin-related diseases

#61

20160022767

2016-01-28

Protein particles comprising disulfide crosslinkers and uses

#62

20160011211

2016-01-14

METHODS TO PREDICT AND PREVENT RESISTANCE TO TAXOID COMPOUNDS

#63

20150368304

2015-12-24

Nucleic acids and proteins from groups A and B

#64

20150328248

2015-11-19

Apoptosis-inducing agent

#65

20150157686

2015-06-11

Treatments of oxidative stress conditions

#66

20130336946

2013-12-19

Fusion proteins and methods for treating HIV infection and AIDS related symptoms

#67

20130143304

2013-06-06

LIGF-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS

#68

20130053270

2013-02-28

METHODS FOR DETERMINING GENE-NUTRIENT INTERACTIONS

#69

20130028885

2013-01-31

Methods to predict and prevent resistance to taxoid compounds

#70

20120202272

2012-08-09

LIGE-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS

#71

20120202258

2012-08-09

LIGE-TYPE TRANSFORMANTS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS

#72

20120202257

2012-08-09

LIGE-TYPE ENZYMES FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS

#73

20120196353

2012-08-02

LIGF-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS

#74

20120196335

2012-08-02

LIGF-TYPE TRANSFORMANTS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS

#75

20120196334

2012-08-02

LIGF-TYPE ENZYMES FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS

#76

20100312045

2010-12-09

Polypeptides comprising an ice-binding activity

#77

20100226856

2010-09-09

Dynamic bio-nanoparticle elements

#78

20100129341

2010-05-27

Fusion proteins of collagen-binding domain and parathyroid hormone

#79

20100105865

2010-04-29

Nucleic acids and proteins from groups A & B

#80

20100036106

2010-02-11

High-Affinity RNA Aptamer Molecule Against Glutathione-S-Transferase Protein

#81

20090312405

2009-12-17

Methods to predict and prevent resistance to taxoid compounds

#82

20090104638

2009-04-23

Methods for Building Atomic Models of Protein Molecules and Determining Drug Candidates Using MGST1

#83

20060258849

2006-11-16

Nucleic acids and proteins from groups A and B

#84

20060210582

2006-09-21

Nucleic acids and proteins from groups A and B

#85

20060210581

2006-09-21

Nucleic acids and proteins from groups A & B

#86

20060210580

2006-09-21

Nucleic acids and proteins from groups A and B

#87

20060210579

2006-09-21

Nucleic acids and proteins from streptococcus groups A & B

#88

20050181415

2005-08-18

Drug metabolizing enzymes

#89

20050074775

2005-04-07

Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi expression

#90

20050019783

2005-01-27

Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression

#91

20050013825

2005-01-20

Vaccine containing the catalytic subunit of telomerase for treating cancer